M Michael Gromiha

InstitutionIndian Institute of Technology Madras
AddressIndia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 1 publications in January 2020 and April 2020 and Spetember 2020 and October 2020 and November 2020 and April 2021 and May 2021 and August 2021
    All Publications
    Bar chart showing 151 publications over 20 distinct years, with a maximum of 13 publications in 2006
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fernandez RA, Quimque MT, Notarte KI, Manzano JA, Pilapil DY, de Leon VN, San Jose JJ, Villalobos O, Muralidharan NH, Gromiha MM, Brogi S, Macabeo APG. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein. J Biomol Struct Dyn. 2021 Aug 31; 1-12. PMID: 34463219.
      Citations:    Fields:    
    2. Rawat P, Sharma D, Srivastava A, Janakiraman V, Gromiha MM. Exploring antibody repurposing for COVID-19: beyond presumed roles of therapeutic antibodies. Sci Rep. 2021 05 13; 11(1):10220. PMID: 33986382.
      Citations: 1     Fields:    Translation:Humans
    3. Yesudhas D, Srivastava A, Sekijima M, Gromiha MM. Tackling Covid-19 using disordered-to-order transition of residues in the spike protein upon angiotensin-converting enzyme 2 binding. Proteins. 2021 09; 89(9):1158-1166. PMID: 33893649.
      Citations: 1     Fields:    Translation:HumansCells
    4. Rawat P, Jemimah S, Ponnuswamy PK, Gromiha MM. Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild? Proteins. 2021 04; 89(4):389-398. PMID: 33210300.
      Citations: 4     Fields:    Translation:HumansCells
    5. Barh D, Tiwari S, Weener ME, Azevedo V, Góes-Neto A, Gromiha MM, Ghosh P. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19. Comput Biol Med. 2020 11; 126:104051. PMID: 33131530.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    6. Yesudhas D, Srivastava A, Gromiha MM. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection. 2021 Apr; 49(2):199-213. PMID: 32886331.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    7. Muralidharan N, Sakthivel R, Velmurugan D, Gromiha MM. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. J Biomol Struct Dyn. 2021 04; 39(7):2673-2678. PMID: 32248766.
      Citations: 89     Fields:    Translation:Humans
    8. Shanmugam A, Muralidharan N, Velmurugan D, Gromiha MM. Therapeutic Targets and Computational Approaches on Drug Development for COVID-19. Curr Top Med Chem. 2020; 20(24):2210-2220. PMID: 32648845.
      Citations: 3     Fields:    Translation:HumansPHPublic Health